Collins Cooper C.
- SEC CIK
- 0001485508
No open-market purchases or sales filed in the past year.
Current role at each company
- TXMD TherapeuticsMD, Inc.Directoras of Nov 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Collins Cooper C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 (view filing) | Aug 22 | 4 days | Collins Cooper C.Director | PPurchase | +4.09K | $1.73 | +$7.08K | +8.5%52.0K after | |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Collins Cooper C.Director | PPurchase | +1.20K | $1.70 | +$2.04K | +2.6%47.9K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Collins Cooper C.Director | PPurchase | +1.00M | $0.58 | +$580.0K | +80.8%2.24M after | |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Collins Cooper C.Director | PPurchase | +1.00M | $0.725 | +$725.0K | +422.2%1.24M after | 2 lots |